Results 61 to 68 of about 31,420 (68)

A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers

Cancer Cell
Xiufeng Pang, Guizhen Zhou, Kewen Hu
exaly  

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

Annals of Oncology, 2013
Thierry Lecomte, David Tougeron, J M Tourani   +2 more
exaly  

A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

Annals of Oncology, 2011
Dongyun Yang, E K Rowinsky
exaly  

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

Cancer Cell
Hongbin Ji, Juntao Gao, Khrystyna Myndzar   +2 more
exaly  

Contact karst of Brkini Hills: Brkinski kontaktni kras:

1994
openaire   +1 more source

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer

Cancer Cell
Caicun Zhou, Chuchu Shao, Libo Luo
exaly  

Contact karst phenomena on the edge of the Galyaság (Gömör-Torna Karst): Kontaktni kras na robu hribovja Galyaság (Slovensky kras):

2001
openaire   +1 more source

A first-in-class EGFR-directed KRAS G12V selective inhibitor

Cancer Cell
Chad V Pecot, Alessandro Porrello, Salma H Azam   +2 more
exaly